missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CILP-1 C-Terminal Fragment Antibody, R&D Systems™

Sheep Polyclonal Antibody
183.00 € - 436.00 €
Specifications
| Antigen | CILP-1 |
|---|---|
| Concentration | LYOPH |
| Dilution | Western Blot 0.1 ug/mL |
| Applications | Western Blot |
| Classification | Polyclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
18716907
![]() |
R&D Systems
AF4477-SP |
25 μg |
183.00 €
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18031962
|
R&D Systems
AF4477 |
100 μg |
436.00 €
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
CILP-1 Polyclonal specifically detects CILP-1 in Human samples. It is validated for Western Blot.Specifications
| CILP-1 | |
| Western Blot 0.1 ug/mL | |
| Polyclonal | |
| Sheep | |
| Human | |
| cartilage intermediate layer protein 1, cartilage intermediate layer protein 1 C1, cartilage intermediate layer protein 1 C2, cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, Cartilage intermediate-layer protein, CILP, CILP1, CILP-1, HsT18872 | |
| CILP | |
| IgG | |
| Affinity Purified | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| LYOPH | |
| Western Blot | |
| Unconjugated | |
| RUO | |
| O75339 | |
| 8483 | |
| Mouse myeloma cell line NS0-derived recombinant human CILP-1 C-Terminal Fragment Arg724-Asn1184 Accession # O75339 | |
| Primary | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Detects human CILP-1 C-Terminal Fragment in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human CILP-1 N-terminal peptide is observed. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title